Incidence and characterization of secondary myelodysplastic syndromes following autologous transplantation

Haematologica

Volumn 85, Issue 4, 2000, Pages 403-409

  Del Cañizo, Ma Consuelo ^a   Amigo, Ma Luz ^a   Hernández, Jesús Ma ^a   Sanz, Guillermo ^a   Núñez, Rosa ^a   Carreras, Enric ^a   Alegre, Adrian ^a   Cuesta, Braulia ^a   Mataix, Rodolfo ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

Alkylating agents; Autologous transplantation; Incidence; Secondary myelodysplastic syndromes

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERFERON; MELPHALAN; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOXANTRONE; PREDNIMUSTINE; PREDNISONE; PROCARBAZINE; TIOGUANINE; VINCRISTINE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CYTOGENETICS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; CYTOGENETICS; FEMALE; HODGKIN DISEASE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROMES; NEOPLASMS, SECOND PRIMARY; SPAIN; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034035112     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Gianni AM, Bregni M, Siena S, et al. High dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma. N Engl J Med 1997; 336:1290-7.
2. Tricot G, Jagannath S, Vesole D, et al. Peripheral blood stem cell transplants for multiple myeloma: identification of favorable variables for rapid engraftment in 225 patients. Blood 1995; 85:588-96.
3. Peters W, Ross M, Vredenburgh JJ, et al. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer. J Clin Oncol 1993; 11:1132-43.
4. Levine EG, Bloomfield CD. Leukemia and myelodys-plastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol 1992; 19:47-84.
5. Park DJ, Koeffler HP. Therapy-related myelodysplastic syndromes. Semin Hematol 1996; 33:256-73.
6. Marolleau JP, Brice P, Morel P, Gisselbrecht C. Secondary acute myeloid leukemia after autologous bone marrow transplantation for malignant lymphomas. J Clin Oncol 1993; 11:590-1.
7. Miller JS, Arthur DC, Litz CE, et al. Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy. Blood 1994; 83:3780-6.
8. Traweek ST, Slovak ML, Nademanee AP, et al. Clonal karyotypic hematopoietic cell abnormalities occurring after autologous bone marrow transplantation for Hodgkin's disease and non-Hodgkin's lymphoma. Blood 1994; 84:957-63.
9. Stone RM, Neuberg D, Soiffer R, et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994; 12:2535-42.
10. Darrington DL, Vose JM, Anderson JR, et al. Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemoradiotherapy and autologous stemcell transplantation for lymphoid malignancies. J Clin Oncol 1994; 12:2527-34.
11. Govindarajan R, Jagannath S, Flick JT, et al. Preceding standard tnerapy is the likely cause of MDS after autotransplants for multiple myeloma. Br J Haematol 1996; 95:349-53.
12. Taylor PR, Jackson GH, Lennard AL, Hamilton PJ, Proctor SJ. Low incidence of myelodysplastic syndrome following transplantation using autologous non-cryopreserved bone marrow. Leukemia 1997; 11: 1650-3.
13. Pedersen-Bjergaard J, Pedersen M, Myhre J, Geisler C. High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia 1997; 11:1654-60.
14. André M, Henry-Amar M, Biaise D, et al. Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. Blood 1998; 92:1933-40.
15. Wheeler C, Khurshid A, Ibrahim J, et al. Low incidence of post-transplant myelodysplasia/acute leukemia (MDS/AML) in NHL patients autotransplanted after cyclophosphamide, carmustine and etoposide (CBV). [abstract] Blood 1997; 90(Suppl 1):4480.
16. Hernández JM, Mecucci C, Beverloo HB, et al. Translocation (11;15)(q23;q14) in three patients with acute non-lymphoblastic leukemia (ANLL): clinical, cytogenetic and molecular studies. Leukemia 1995; 9: 1162-6.
17. ISCN. F. Mitelman ed. Guidelines for Cancer Cytogenetics supplement to an International System for Human Genetics nomenclature. Basel: S. Karger; 1995.
18. Amigo ML, del Cañizo MC, Hernández JM, et al. Clonal myelodysplastic cells present in apheresis product before transplantation. Leukemia 1998; 12:1497-9.
19. Deeg HJ, Socié G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91:1833-44.
20. Laughlin MJ, McGaughey DS, Crews JR, et al. Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant. J Clin Oncol 1998; 16:1008-12.
21. Milligan DW, Ruiz de Elvira MC, Kolb HJ, et al. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol 1999; 106:1020-6.
22. Wilson CS, Traweek ST, Slovak ML, Niland JC, Forman SJ, Brynes RK. Myelodysplastic syndrome occurring after autologous bone marrow transplantation for lymphoma. Morphologic features. Am J Clin Pathol 1997; 108:369-77.
23. San Miguel JF, Sanz GF, Vallespí T, del Canizo MC, Sanz MA. Myelodysplastic syndromes. Crit Rev Oncol Hemat 1996; 23:57-93.
24. Pedersen-Bjergaard J, Philip P, Larsen SO, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute non-lymphocytic leukemia. Blood 1990; 76:1083-91.
25. Lambertenghi Deliliers G, Annaloro C, Pozzoli E, et al. Cytogenetic and myelodysplastic alterations after autologous hemopoietic stem cell transplantation. Leuk Res 1999; 23:291-7.
26. Andreasson P, Johansson B, Arheden K, Billstrom R, Mitelman F, Hoglund M. Deletions of CDKN1B and ETV6 in acute myeloid leukemia and myelodysplastic syndromes without cytogenetic evidence of 12p abnormalities. Gene Chromosome Canc 1997; 19:77-83.
27. Golub TR, Barker GF, Bohlander SK, et al. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc Natl Acad Sci USA 1995; 92:4917-21.
28. Offit K, Parsa NZ, Gaidano G, et al. 6q deletions define distinct clinico-pathologic subsets of non-Hodgkin's lymphoma. Blood 1993; 82:2157-62.
29. Offit K, Louie DC, Parsa NZ, et al. Clinical and morphological features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 1994; 83:2611-8.
30. Mitelman F. Catalog of chromosome aberrations in cancer. CD-ROM. New York: Wiley-Liss; 1998.
31. th Meeting A.S.H. Miami Beach, Florida. December, 4-8, 1998. Abstract 1278.
32. Abruzzese E, Radford JE, Miller JS, et al. Detection of abnormal pretransplant clones in progenitor cells of patients who developed myelodysplasia after autologous transplantation. Blood 1999; 94:1814-9.